Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Tg Therapeuticscmn (TGTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 615,797
  • Shares Outstanding, K 87,971
  • Annual Sales, $ 150 K
  • Annual Income, $ -173,480 K
  • 60-Month Beta 2.25
  • Price/Sales 3,906.61
  • Price/Cash Flow N/A
  • Price/Book 30.84

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.44
  • Number of Estimates 3
  • High Estimate -0.36
  • Low Estimate -0.48
  • Prior Year -0.59
  • Growth Rate Est. (year over year) +25.42%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.48 +6.48%
on 05/15/19
8.51 -18.92%
on 05/07/19
-1.05 (-13.21%)
since 04/22/19
3-Month
4.79 +44.05%
on 02/25/19
9.30 -25.81%
on 04/01/19
+2.13 (+44.65%)
since 02/22/19
52-Week
3.32 +107.83%
on 12/24/18
16.00 -56.88%
on 06/04/18
-6.95 (-50.18%)
since 05/22/18

Most Recent Stories

More News
TG Therapeutics Announces Data Presentations at Upcoming Medical Meetings

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of upcoming data presentations at the 55 American Society of Clinical Oncology (ASCO) annual meeting, to be held May 31 - June 4, 2019,...

TGTX : 6.90 (-1.43%)
Tg Therapeutics Shares Up 40.6% Since SmarTrend's Buy Recommendation (TGTX)

SmarTrend identified an Uptrend for Tg Therapeutics (NASDAQ:TGTX) on January 7th, 2019 at $4.84. In approximately 4 months, Tg Therapeutics has returned 40.64% as of today's recent price of $6.80.

TGTX : 6.90 (-1.43%)
TG Therapeutics: 1Q Earnings Snapshot

NEW YORK (AP) _ TG Therapeutics Inc. (TGTX) on Friday reported a loss of $35.2 million in its first quarter.

TGTX : 6.90 (-1.43%)
TG Therapeutics Provides Business Update and Reports First Quarter 2019 Financial Results

TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the first quarter ended March 31, 2019 and recent company developments.

TGTX : 6.90 (-1.43%)
TG Therapeutics to Host Conference Call on First Quarter 2019 Financial Results and Business Update

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, Friday, May 10, 2019 at 8:00 AM ET to discuss results for the first quarter of 2019 and provide a business outlook...

TGTX : 6.90 (-1.43%)
Shares of TGTX Up 69.6% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Tg Therapeutics (NASDAQ:TGTX) on January 7th, 2019 at $4.84. In approximately 4 months, Tg Therapeutics has returned 69.60% as of today's recent price of $8.20.

TGTX : 6.90 (-1.43%)
TG Therapeutics Announces Long-term Follow-up Data from the Phase 2 Trial of Ublituximab in Patients with Multiple Sclerosis at the American Academy of Neurology 71st Annual Meeting

TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical company dedicated to developing medicines for patients with B-cell mediated diseases, today announced the presentation of long-term follow-up data...

TGTX : 6.90 (-1.43%)
Tg Therapeutics Has Returned 64.2% Since SmarTrend Recommendation (TGTX)

SmarTrend identified an Uptrend for Tg Therapeutics (NASDAQ:TGTX) on January 7th, 2019 at $4.84. In approximately 4 months, Tg Therapeutics has returned 64.22% as of today's recent price of $7.94.

TGTX : 6.90 (-1.43%)
Uptrend Call Working As Tg Therapeutics Stock Rises 62.4% (TGTX)

SmarTrend identified an Uptrend for Tg Therapeutics (NASDAQ:TGTX) on January 7th, 2019 at $4.84. In approximately 4 months, Tg Therapeutics has returned 62.36% as of today's recent price of $7.85.

TGTX : 6.90 (-1.43%)
Can Core MedSurg Segment Drive Stryker's (SYK) Q1 Earnings?

Solid segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine along with an upbeat 2019 view are likely to support Stryker (SYK) in Q1. But integration risks might be a dampener.

TGTX : 6.90 (-1.43%)
SYK : 185.95 (+0.27%)
GWPH : 187.21 (+1.74%)
NSTG : 26.79 (-0.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade TGTX with:

Business Summary

TG Therapeutics, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The Company is focused on the development of a monoclonal antibody for the treatment of various...

See More

Key Turning Points

2nd Resistance Point 7.19
1st Resistance Point 7.09
Last Price 6.90
1st Support Level 6.82
2nd Support Level 6.65

See More

52-Week High 16.00
Fibonacci 61.8% 11.16
Fibonacci 50% 9.66
Fibonacci 38.2% 8.16
Last Price 6.90
52-Week Low 3.32

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar